Cargando…
Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
The occurrence of Clostridium difficile colitis is on the rise and has become more difficult to manage with standard therapy. Thus, the need for alternative treatments is essential. Tigecycline is a glycylcycline antibiotic that has been shown to be effective against C. difficile through several pub...
Autores principales: | Lao, Dominador, Chiang, Tom, Gomez, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399506/ https://www.ncbi.nlm.nih.gov/pubmed/22829841 http://dx.doi.org/10.1155/2012/702910 |
Ejemplares similares
-
Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin
por: Tannous, George, et al.
Publicado: (2010) -
Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection
por: Waqas, Muhammad, et al.
Publicado: (2022) -
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
por: Britt, Nicholas S., et al.
Publicado: (2014) -
Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
por: Mahabir, Shanti, et al.
Publicado: (2013) -
Vancomycin Enemas as Adjunctive Therapy for Clostridium difficile Infection
por: Malamood, Mark, et al.
Publicado: (2015)